Literature DB >> 22155078

Analysis of the active-site mechanism of tyrosyl-DNA phosphodiesterase I: a member of the phospholipase D superfamily.

Stefan Gajewski1, Evan Q Comeaux, Nauzanene Jafari, Nagakumar Bharatham, Donald Bashford, Stephen W White, Robert C A M van Waardenburg.   

Abstract

Tyrosyl-DNA phosphodiesterase I (Tdp1) is a member of the phospholipase D superfamily that hydrolyzes 3'-phospho-DNA adducts via two conserved catalytic histidines-one acting as the lead nucleophile and the second acting as a general acid/base. Substitution of the second histidine specifically to arginine contributes to the neurodegenerative disease spinocerebellar ataxia with axonal neuropathy (SCAN1). We investigated the catalytic role of this histidine in the yeast protein (His432) using a combination of X-ray crystallography, biochemistry, yeast genetics, and theoretical chemistry. The structures of wild-type Tdp1 and His432Arg both show a phosphorylated form of the nucleophilic histidine that is not observed in the structure of His432Asn. The phosphohistidine is stabilized in the His432Arg structure by the guanidinium group that also restricts the access of nucleophilic water molecule to the Tdp1-DNA intermediate. Biochemical analyses confirm that His432Arg forms an observable and unique Tdp1-DNA adduct during catalysis. Substitution of His432 by Lys does not affect catalytic activity or yeast phenotype, but substitutions with Asn, Gln, Leu, Ala, Ser, and Thr all result in severely compromised enzymes and DNA topoisomerase I-camptothecin dependent lethality. Surprisingly, His432Asn did not show a stable covalent Tdp1-DNA intermediate that suggests another catalytic defect. Theoretical calculations revealed that the defect resides in the nucleophilic histidine and that the pK(a) of this histidine is crucially dependent on the second histidine and on the incoming phosphate of the substrate. This represents a unique example of substrate-activated catalysis that applies to the entire phospholipase D superfamily.
Copyright © 2011. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22155078      PMCID: PMC3265611          DOI: 10.1016/j.jmb.2011.11.044

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  52 in total

1.  Electrostatics of nanosystems: application to microtubules and the ribosome.

Authors:  N A Baker; D Sept; S Joseph; M J Holst; J A McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

2.  Alterations in the catalytic activity of yeast DNA topoisomerase I result in cell cycle arrest and cell death.

Authors:  M D Megonigal; J Fertala; M A Bjornsti
Journal:  J Biol Chem       Date:  1997-05-09       Impact factor: 5.157

3.  A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations.

Authors:  Yong Duan; Chun Wu; Shibasish Chowdhury; Mathew C Lee; Guoming Xiong; Wei Zhang; Rong Yang; Piotr Cieplak; Ray Luo; Taisung Lee; James Caldwell; Junmei Wang; Peter Kollman
Journal:  J Comput Chem       Date:  2003-12       Impact factor: 3.376

Review 4.  Macroscopic electrostatic models for protonation states in proteins.

Authors:  Donald Bashford
Journal:  Front Biosci       Date:  2004-05-01

5.  A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases.

Authors:  S W Yang; A B Burgin; B N Huizenga; C A Robertson; K C Yao; H A Nash
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 6.  Topoisomerase I inhibitors: camptothecins and beyond.

Authors:  Yves Pommier
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

7.  The crystal structure of human tyrosyl-DNA phosphodiesterase, Tdp1.

Authors:  Douglas R Davies; Heidrun Interthal; James J Champoux; Wim G J Hol
Journal:  Structure       Date:  2002-02       Impact factor: 5.006

8.  Explorations of peptide and oligonucleotide binding sites of tyrosyl-DNA phosphodiesterase using vanadate complexes.

Authors:  Douglas R Davies; Heidrun Interthal; James J Champoux; Wim G J Hol
Journal:  J Med Chem       Date:  2004-02-12       Impact factor: 7.446

9.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.

Authors:  Y H Hsiang; R Hertzberg; S Hecht; L F Liu
Journal:  J Biol Chem       Date:  1985-11-25       Impact factor: 5.157

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  13 in total

1.  Tyrosyl-DNA Phosphodiesterase I a critical survival factor for neuronal development and homeostasis.

Authors:  Robert C A M van Waardenburg
Journal:  J Neurol Neuromedicine       Date:  2016

2.  A New Method, "Reverse Yeast Two-Hybrid Array" (RYTHA), Identifies Mutants that Dissociate the Physical Interaction Between Elg1 and Slx5.

Authors:  Ifat Lev; Keren Shemesh; Marina Volpe; Soumitra Sau; Nelly Levinton; Maya Molco; Shivani Singh; Batia Liefshitz; Shay Ben Aroya; Martin Kupiec
Journal:  Genetics       Date:  2017-05-05       Impact factor: 4.562

3.  Overexpression screens identify conserved dosage chromosome instability genes in yeast and human cancer.

Authors:  Supipi Duffy; Hok Khim Fam; Yi Kan Wang; Erin B Styles; Jung-Hyun Kim; J Sidney Ang; Tejomayee Singh; Vladimir Larionov; Sohrab P Shah; Brenda Andrews; Cornelius F Boerkoel; Philip Hieter
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-22       Impact factor: 11.205

4.  Tyrosyl-DNA phosphodiesterase I catalytic mutants reveal an alternative nucleophile that can catalyze substrate cleavage.

Authors:  Evan Q Comeaux; Selma M Cuya; Kyoko Kojima; Nauzanene Jafari; Keith C Wanzeck; James A Mobley; Mary-Ann Bjornsti; Robert C A M van Waardenburg
Journal:  J Biol Chem       Date:  2015-01-21       Impact factor: 5.157

5.  Probing the evolutionary conserved residues Y204, F259, S400 and W590 that shape the catalytic groove of human TDP1 for 3'- and 5'-phosphodiester-DNA bond cleavage.

Authors:  Evgeny Kiselev; Thomas S Dexheimer; Christophe Marchand; Shar-Yin Naomi Huang; Yves Pommier
Journal:  DNA Repair (Amst)       Date:  2018-05-02

6.  SUMO modification of the neuroprotective protein TDP1 facilitates chromosomal single-strand break repair.

Authors:  Jessica J R Hudson; Shih-Chieh Chiang; Owen S Wells; Chris Rookyard; Sherif F El-Khamisy
Journal:  Nat Commun       Date:  2012-03-13       Impact factor: 14.919

7.  Dysregulated human Tyrosyl-DNA phosphodiesterase I acts as cellular toxin.

Authors:  Selma M Cuya; Evan Q Comeaux; Keith Wanzeck; Karina J Yoon; Robert C A M van Waardenburg
Journal:  Oncotarget       Date:  2016-12-27

8.  Design, Synthesis, and Molecular Docking Study of New Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors Combining Resin Acids and Adamantane Moieties.

Authors:  Kseniya Kovaleva; Olga Yarovaya; Konstantin Ponomarev; Sergey Cheresiz; Amirhossein Azimirad; Irina Chernyshova; Alexandra Zakharenko; Vasily Konev; Tatiana Khlebnikova; Evgenii Mozhaytsev; Evgenii Suslov; Dmitry Nilov; Vytas Švedas; Andrey Pokrovsky; Olga Lavrik; Nariman Salakhutdinov
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-01

9.  Gene flow and biological conflict systems in the origin and evolution of eukaryotes.

Authors:  L Aravind; Vivek Anantharaman; Dapeng Zhang; Robson F de Souza; Lakshminarayan M Iyer
Journal:  Front Cell Infect Microbiol       Date:  2012-06-29       Impact factor: 5.293

Review 10.  Tyrosyl-DNA phosphodiesterases: rescuing the genome from the risks of relaxation.

Authors:  Ajinkya S Kawale; Lawrence F Povirk
Journal:  Nucleic Acids Res       Date:  2018-01-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.